HuMax CD38
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HuMax CD38, covering 2025-04-25 to 2025-04-25. Get the full timeline:
Most recent: Clinical Trial Update: A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma [Phase 1]